期刊文献+

荧光聚合酶链反应检测急性早幼粒细胞白血病PML/RARα的临床价值 被引量:1

下载PDF
导出
摘要 实时定量逆转录聚合酶链反应是目前最精确地检测急性白血病微小残留病的方法,对急性早幼粒细胞PML/RARα融合基因表达量的测定及动态变化监测,取得PML/RARα融合基因的表达拷贝数,对临床治疗、预防复发、延长患者生存期,最终治愈白血病具有重要的指导意义。
作者 赵峻峰 朱平
出处 《国外医学(输血及血液学分册)》 2005年第5期391-394,共4页 Foreign Medical Sciences(Section of Blood Transfusion and Heanatology)
  • 相关文献

参考文献25

  • 1陈赛娟,余怀勤.用逆转录酶/多聚酶链反应检测早幼粒细胞白血病PML—RARa融合基因[J].中华血液学杂志,1993,14(1):3-5. 被引量:12
  • 2李志刚,吴敏媛,朱平,胡亚美.白血病29种染色体畸变形成的融合基因分析[J].中华儿科杂志,2001,39(11):682-685. 被引量:32
  • 3Sanz MA. All-trans retinoic acid anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia. Blood, 2004, 104 (12) : 3490-3493.
  • 4Sanz MA, Martin G, Lo Coco F. Choice of chemotherapy in induction, consolidation and maintenance in acute promyelocytic leukaemia. Best Pract Res Clin Haematol, 2003, 16(3): 433-451.
  • 5Gu BW, Hu J, Xu L, et al. Feasibility and clinical significance of real-time quantitative RT-PCR assay of PML-RARa pha fusion transcript in patients with acute promyelocytic leukemia. Hematol J, 2001, 2(5): 330-340.
  • 6Jureic JG. Monituring PML/RARα pha in acute promyelocytic leukemia. Gurr Ohcol, 2003, 5(5): 391-398.
  • 7Schnittger S, Weisser M, Schoch C, et al, New score predicting for prognosis in PML-RARα -k, AML/ETO -k, CBF/MYH11 acute myeloid leukemia based on quantification of fusion transcripts. Blood, 2003, 102:2746-2755.
  • 8Higuchi T, Kizaki M, Omine M. Induction of differentiation of retinoic acid-resistant acute promyelocytic leukemia cells by the combination of all-trans retinoic acid and granulocyte colony-stimulating factor. Leuk Res, 2004, 28(5): 525-532.
  • 9Daruka M, Alan FL. Targeting the multidrug resistance-1 transporter inAML: molecular regulation and therapeutic strategies. Blood, 2004,104(7):1940-1951.
  • 10Tobal K, Moore H, Macheta M, et al. Monitoring minimal residual disease and predicting relapse in APL by quantitating PML-RARalpha transcripts with a sensitive competitive RT-PCR method. Leukemia, 2001, 15(7): 1060-1065.

二级参考文献28

  • 1Warrell RP Jr, de The H, Wang ZY, et al. N Engl J Med, 1993,329:177.
  • 2Mann KK, Shao W, Miller WH J r. Curt Oncol Rep 2001,3 : 329 : 177.
  • 3Lefebvre P. Dombret H, Cordonnier C, et al, Leukemia, 2000,14 : 1006.
  • 4Muindi J, Frankel SR, Miller WH, et al. Blood, 1992,79: 299.
  • 5Kizaki M,Ueno H,Yamazoe Y,et al. Blood,1996,87:725.
  • 6Boylan JF, Gudas LJ. J Biol Chem, 1992,267:21486.
  • 7Adamson PC, Balin, FM, et al. Cancer Res, 1993,53:472.
  • 8Delva L, Comic M, Balitrand N, et al. Blood, 1993,82: 2175.
  • 9Comic M,Delva L,Castaigne S,et al. Leukemia, 1994,8(suppl 2):Sl6.
  • 10Matsushita H, Kizaki M, Kobayashi H, et al. Blood, 198,91 : 2452.

共引文献44

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部